Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.

Authors

David Cohen, Marie Raffin, Roberto Canitano, Nicolas Bodeau

Title

Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects.

Journal

Research in Autism Spectrum Disorders

Year

2013

Volume

7

Issue

1

Page(s)

pp. 167-175.

Abstract Link

Read Abstract (New Window)

Publication Format

Journal Article

Efficacy Study/Review

Yes

Scientific Validity

Selective/Systematic Review, Peer-Reviewed, Meta-Analysis

Keywords

Adolescent / Secondary School Age, Antipsychotics, Aripiprazole, Atypical, Autism, Child/Children, Drowsiness/Sedation, Extrapyramidal, Intervention, Learning / Intellectual Disability, Medication, Risperidone, Side Effects, Weight Gain/Loss

---

If you know of any other publications we should list on this page please email info@informationautism.org

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.

---

Related Interventions

• Aripiprazole and Autism

---

Publications | Publications Database | Search Publications